History

HISTORY OF INSTITUTE OF OBSTETRICS AND GYNAECOLOGY

Institute of Obstetrics and Gynaecology was the first allopathic maternity hospital in British India to address women's reproductive health. There is perhaps no other acreage in Egmore that is as filled with hope as this hospital. The Institute of Obstetrics and Gynaecology (IOG) and Government Hospital for Women and Children, fondly called MH (maternity hospital) by generations of doctors, nurses, students and allied staff is a tertiary healthcare centre. Age (189-years old) has not defeated its ranks and it has gone above and beyond doing what it was first founded for in 1844 – delivering babies.

It was established on the banks of the Cooum near the Egmore Railway Station under the superintendentship of stalwarts such as Drs WS Thompson and James Shaw — who instituted a professorship in midwifery at the Madras Medical College — but moved to its present location on Pantheon Road in the 1880s because of the annual flooding of the river.

Laid out in the shape of a female pelvis, the new structure came up on Pantheon Road, under the guidance of Major General G.G. Gifford, who is commemorated with a block in his name on the campus. The new hospital was completed in 1881 in Egmore and by 1900 had expanded to five blocks with a total of 140 beds. IOG has conducted so many difficult deliveries. the imprisoned former-Queen of Burma – Supayalat – gave birth in IOG after a long and Excruciating labour. IOG hospital has delivered the exiled queen, Supayalat, of Burma in the late 1800s and also actors such as Vijay.

The Gifford School named after Major General Gifford, a former superintendent of the hospital still remains untouched which was setup in 1911. It has the most fascinating specimens and ancient obstetrics instruments.

The hospital was to be headed by several noted medical practitioners. IOG hosted the first All-India Obstetrics and Gynaecological Congress in 1936. The venue was the Museum Theatre and inaugurating it was Dr.Ida Scudder of CMC Vellore, with Dr. Sir A. Lakshmanaswami Mudaliar in the chair. He was also the first Indian to be the Superintendent of IOG, occupying the post between 1939 and 1942.

When it was constructed, the buildings resembled the shape of women's pelvis and sacrum. But over the years, portions were demolished to make way for multi-rise buildings that could accommodate more patients. Dr. AL Mudhaliar, was the first Indian to head the hospital in the years before the second world war. Earlier, the red brick wings had large high sealing rooms, broad verandahs that lead to a statue of a mother and child. Today, much of that has been replaced by waiting area and AL Mudhaliar block. Now IOG has 1075 beds with 95%-100% occupancy and now has separate building for Obstetrics and Gynaecology. AL Mudaliar block is for obstetrics

New building is opened from July 2022 exclusively for Gynaecology and Fertility OPD. VIA, VILI and Colposcopy facilities are available at gynaec OPD. Has separate Operation theatres for Gynaecologic surgeries including laproscopic and endoscopic surgeries in that new building. Pre-operative and Post-operative gynaecology wards is there in the same building.

Standing proudly, IOG Egmore has departments Surgical Oncology, Medical Oncology, Radiotherapy, family planning, assisted reproductive techniques, Endocrinology apart from conducting cities most high risk deliveries.

IOG, Egmore to get 1st Public Fertility treatment centre with IVF facilities. To the relief of thousands of poor patients who otherwise cannot afford infertility treatment in private hospitals, the State government on 28th April 2023 announced that it will establish infertility clinics that offer in vitro fertilisation (IVF) treatment at the Institute of Obstetrics and Gynaecology in Egmore at a cost of Rs 2.5 crores. 2nd floor of the Gynaec-Surgical block is completely dedicated to fertility clinic. As of Now Ovulation induction and IUI is being done at FRC OPD. SSG, HSG, DHL, septal resection and other necessary treatments available are being given to the patients.

The hospital became a teaching centre with postgraduate and diploma courses in 1930 under the Madras Medical College. In 1952, it became one of three postgraduate institutes of Madras city, and that marked the beginning of the Institute of Obstetrics and Gynaecology at the Maternity Hospital. Dr. R.K.K. Thampan was the first Director.

This Institute has intake of 55 post-graduates/year. This hospital is recognised as a centre of excellence, conducts around 15,000 – 20,000 deliveries annually. Most of them being high risk cases.

GIFFORD SCHOOL

Faculty & Residents

Staff Image

Dr.K. Kalaivani

Director/HOD

List of Faculty

S.No Name of the Residents joined in the year 2020 Name of the Residents joined in the year 2021 Name of the Residents joined in the year 2022
1 - - -

Facility & Clinical Care

1. Dedicated Obstetrics ICU and HDU
  • Dedicated Obstetrics ICU with 14 beds
  • Ventilatory support
  • Labour cot with NICU corner
  • Defibrillator
2. Infertility Clinic
  • Hormonal profile
  • Follicular study
  • Ovulation Induction
  • Semen preparation
  • IUI
  • HSG
  • Laparoscopy services
3. High Risk AN OP
  • Antenatal yoga and exercises
  • OGCT screening
4. Casualty (24x7)
  • Antenatal and Gynae emergencies
  • Zero delay casualty
  • Rapid screening test
  • Ultrasonogram and ECG available
5. Labour Ward
  • Clean and Septic labour rooms
  • 24x7 Free delivery services
  • Emergency Obstetrics services
  • Newborn resuscitation services
6. Laboratory Services
  • 24x7 Emergency laboratory services
  • Clinical pathology
  • Clinical Biochemistry
  • Histopathology
  • Microbiology
7. Ambulance Services
  • Available 24x7
8. Cancer Screening OP
  • Pap smear
  • Colposcopy
9. Medical Oncology Clinic
  • OP
  • Inpatient ward
  • Administration of chemotherapy drugs
10. Surgical Oncology Unit
  • OP
  • Gynae onco-surgeries
11. Family Planning Services
  • OP
  • Safe abortion services
  • Contraception services
  • Sterilisation services
12. Gynaecological Laparoscopic Surgeries
  • Minimally invasive surgery
13. Blood Bank
  • Blood availability 24x7
  • Blood donation camps
14. Gynaecology Endocrine Clinic
15. Menopause Clinic
16. Adolescent Clinic
17. High-end NICU Care Centre
18. Breast Milk Bank
19. Postpartum Mental Health Clinic

Academic Forum

CME / CONFERENCE
S.NO Date CME / CONFERENCE – Title University / TNMSC Credits / both if present State or National level or institute level
1 24.2.2022 CME on recent advances in gynaec oncology surgery - STATE LEVEL
WORKSHOP / TRAINING PROGRAMME
S.NO Date WORKSHOP / TRAINING with Title University / TNMSC Credits / both if present State or National level or Institute
1 22.06.2022 Workshop on ENDOGYNAECOLOGY - STATE LEVEL
QUIZ / COMPETITIONS
S.NO Date Quiz / Competitions with Title University / TNMSC Credits / both if present Prizes awarded to a. Inter or Intra – Collegiate Level
b. State or National level
1 04.08.2023 BREAST WEEK FEEDING QUIZ - Dr. Sangeetha
Dr. Sivasankari
Dr. Kaviya
INTRA COLLEGE
Other Events
S.NO Date Other events with Title Details
1 - - -

Scientific Forum

Completed Projects till November 2023
Ongoing Projects
Sponsored Projects
Publications

Awards & Achievements

S.NO Date/Month & Year Name of the Awards & achievements received Name of the awardee with designation District level / State level / National level Images
1 02/01/2020 FIRST PRIZE IN POSTER ON TNFOGA DR.RAMYA JUNIOR RESIDENT District View

Guests Lectures

UROGYNAECOLOGY & PELVIC SURGERY

MENOPAUSE MANAGEMENT

Success Stories

We are proud that IOG, Egmore is LaQshya certified centre. On May 2023 we received National LaQshya certification. Proud and happy to offer Public good respectful care and with good Infrastructure. All doctors and staffs are LaQshya trained.

1 SUCCESS STORY 1: 2020
+
PREGNANCY WITH ADVANCED SEROUS OVARIAN CARCINOMA – SUCCESSFUL FETO-MATERNAL OUTCOME
  • 29 year old Prmigravida, Mrs.X 20 weeks of gestation, was referred to tertiary centre for management of ovarian cyst complicating pregnancy. USG showed multi-loculated cyst with septations in left ovary. Lesion was found to be progressively increasing in size. MRI done which revealed T2 hyperintense lesion of size 6.75x6cms with multiple septations in the left ovary. Tumor markers were done and found to be raised. CA-125- 671.

  • Surgical oncologist and medical oncologist opinion was obtained and uterus sparing staging laparotomy was done in mid-trimester at 24weeks. Pathological results revealed Micro-papillary variant of serous carcinoma – invasive type with omental deposits. – STAGE III A. Post operatively patient was given 4 cycles of chemotherapy antenatally. (Carboplatin x 2 cycles and Carboplatin with cyclophosphamide x 2 cycles). Elective LSCS along with Right salpingo-ophrectomy was done at 38weeks. After LSCS patient received 2 cycles of Chemotherapy. Patient is now under regular follow up in medical oncology with no recurrence. Mother and baby are healthy.

2 SUCCESS STORY 2: 2021
+
LIMB GRIDLE MUSCULAR DYSTROPHY COMPLICATING PREGNENCY
  • A 33 years old primi Ms-1Year 147 cm/LMP 23.8.20 EDD 30.5.2021 presented in AN opd with single intra uterine gestation of 35w+6 days.

  • History of viral illness 6-7 years back followed by weakness of lower limbs with difficulty in walking/squatting position/combing hair/buttoning dress H/o of sibling who died of muscular dystrophy (respiratory depression) Patient had tested Covid positive Primary cesarean section done, Boy baby. Weight – 2.6 kg. Post partum, Mother and baby was healthy.

3 SUCCESS STORY 3: 2022
+
SEVERE PULMONARY HYPERTENSION COMLICATING PREGNANCY

A Case of 28years old, G2P1L1, Previous one LSCS presented at 32 weeks with complaints of breathlessness for one month, aggrevates on walking for few steps, (NYHA – 111). Admitted in ICU, Echo done and was found to have severe Pulmonary Hypertension (TRPG-72mmHg). Rheumatology opinion obtained, found to have connective tissue disorder – Anti-SS-A and Anti-SS-B Positive. Patient was started on diuretics, Vasodilators(T.Sildenafil), HCQ, Steroids and MgSO4 for neuroprotection. Emergency LSCS done with Cardiologist standby under general anaesthesia at 32weeks + 4 days. Intra-op and Post-op period was uneventful. Post operatively cardiologist opinion obtained and T.Bosentan was started. Appropriate treatment with Multi-disciplinary approach at right time had saved mother’s life. Now she is in regular cardioilogy follow up. Alive and healthy. T.Bosentan 10 tablets costs 800 rupees. But this all medications was given free of cost in IOG and RGGGH.

4 SUCCCESS STORY 4
+
RETROPERITONEAL TERATOMA IN PREGNANT WOMEN-RARE PRESENTATION – SUCCESSFUL FETOMATERNAL OUTCOME

Retroperitoneal tumours originating from retroperitoneum without originating from major organs are rare. 70-80% of the primary retro-peritoneal tumours are malignant. Most common malignant tumours in this region are sarcomas. Most common benign lesion is lipoma and fibromas.

  • CASE REPORT:26 years old G2P1L1, 15weeks 5 days gestational age came to OPD with incidental finding of dermoid cyst. Routine antenatal screening and MRI showed mass of size 29x17x11.8cms well defined abdominopelvic lesion with cystic and solid areas – probably dermoid cyst. Tumour markers were within normal limits.
  • MANAGEMENT:Elective Laprotomy done at 17weeks of Gestation. Large mass 20x10cms displacing left ureter and kidney posteriorly, not infiltrating any vital organs. Mass resected and sent for biopsy – HPE revealed benign mature teratoma showing long bones with marrow material – possibility of fetiform teratoma. Patient came for routine antenatal checkups. Delivered by labour natural at term with no intra-partum and post-partum complications. USG done after 6 months – no significant abnormality.
5 SUCCESS STORY – 5: 2023
+
1st CASE OF NEONATAL ALLO-IMMUNE THROMBOCYTOPENIA – GOOD FETO-MATERNAL OUTCOME
  • A case of BOH, booked and immunized at GG Pettai. previous baby died at 21 days on March 2022.The patient and the baby was referred to ICH for intracranial hemorrhage in march 2022 from chengalpattu medical college and the baby was evaluated in ICH for human placental antigen genotyping and HPA 3b and HPA 15b incompatability detected between the mother and baby and so this patient was advised to review at pediatric ICH hematology department for next pregnancy in march 2022.
  • So in this pregnancy,on 4.7.23, at 15weeks of Gestational age, patient referred from chengalpattu medical college to pediatric hematology department ICH and IOG for further mangament.
  • From pediatric department ICH, patient was discussed with Dr. Bipin kulkarni, NIIH, mumbai.
  • Patient was advised to give immunoglubulins 30gram/week till delivery.As per hematologist opinion, patient was admitted and intravenous immunoglobulin (IVIGs)was planned weekly once.
  • Initially IV IGs Obtained from guindy since cost of IVIGs high
    1. 1st dose given On 4.8.23(6 vials)
    2. 2nd dose given on 11.8.23(6 vials)
    3. 3rd dose given on 25.8.23(6 vials)
  • Totally 18 vials given for the patient.12 vials purchased from TNMSC 6Vials from RGGGH Since IVIGS stock was exhausted in our hospital. NHM director was approached by Director of Institute. NHM accepted to issue the fund under operational cost for purchasing IVIGS. So totally 66vials(11doses given)
  • Immunoglobulin were started weekly once upto 34weeks.On 14.11.23 patient admitted with draining pv, so inview of Prev lscs in labour emegency caesearean section was done. She delivered a preterm girl baby of weight 2.47kg on 14.11.23@8:02am So totally an amount of RS 3,34,416 was spent for this patient through our CMCHIS fund for preventing the transmission of neonatal alloimmune thrombocytopenia for the baby. This is the first case of neonatal alloimmune thrombocytopenia delivered at IOG. We are proud to have the first case. The mother and the baby doing fine now.
6 SUCCESS STORY 6: 2023
+
OHVIRA SYNDROME
  • A 14 year old came with c/o reduced menstrual flow for past 2 years Associated with lower abdominal pain. Patient evaluated. Ultrasound report- right renal agenesis with obstructed hemi vagina causing right sided hematometrocolpos - suggestive pf Herlyn Werner Wunderlich syndrome/OHVIRA syndrome
  • MRI pelvis finding- Uterus didelphys with right hematocollis, obstructed hemi vagina and absent right kidney in right renal fossa. Patient was assessed and planned for laparoscopy assisted hematocollis drainage. After drainage patient on follow up on op basis Post op USG shows no evidence of collection in uterine cavities, no free fluid abdomen. Patient is symptomatically better now
7 SUCCESS STORY 7: 2023
+
SUCCESS STORY 7
  • We have done the first case of Laparoscopic Cesarean scar ectopic excision and repair at Institute of Obstetrics and Gynecology, Egmore.
  • She is a 36 yr old G2P1L1, with previous Cesarean section, with 8 weeks gestation at the cesarean scar site. beta hcg - 63000. This Scar ectopic is very rare presentation. Laproscopic excision has reduced morbidity and period of hospital stay.
8 SUCCESS STORY 8
+
CARCINOSARCOMA OF OVARY
  • Diagnosis: Carcinosarcoma of ovary (Incidence: 1.12%) – Rare case
  • Patient: 43 years old, P2L2
  • Chief Complaint: Abdominal pain, more on the right side
  • Investigations:
    • CA-125: 147
    • USG (21/09/2023): Right complex ovarian cyst with internal septations and solid component
    • CECT Abdomen (23/09/2023): Right adnexal malignant lesion (11x12.5 cm), likely of right ovarian origin
  • Procedure: Staging laparotomy followed by:
    • TAH (Total Abdominal Hysterectomy)
    • BSO (Bilateral Salpingo-Oophorectomy)
    • Infra-colic omentectomy
    • Bilateral pelvic lymph node dissection
    • Specimens sent for HPE
  • Intra-operative Findings:
    • Right adnexal cyst – 15x12 cm, adherent to anterior uterine wall and bladder
    • Right fallopian tube – stretched out
    • Uterus size – 8–10 weeks
  • Transfusions:
    • Intra-op: 1 unit PRBC
    • Post-op: 3 units PRBC
  • HPE Report: Carcinosarcoma – Homologous type
  • FIGO Stage: 1C
  • Markers: HER2 (IHC) done – reports awaited
  • Plan: Start Trastuzumab if HER2 positive
9 SUCCESS STORY 9
+
FERTILITY SPARING TREATMENT FOR ENDOMETRIAL CARCINOMA
  • Patient: 27 years old, Nulligravida, MS 1½ years
  • Reason for Admission: AUB-E (Abnormal Uterine Bleeding – Endometrial) for evaluation
  • Biopsy (18/10/2023): Hysteroscopy-guided biopsy showed Endometrioid endometrial adenocarcinoma, Grade 1
  • Ultrasound (USG):
    • Endometrial hyperplasia – 2.7 cm
    • Complex cystic degeneration noted in endometrial cavity
  • MRI Pelvis (06/10/2023):
    • Stage 1A carcinoma endometrium
    • Bilateral PCOS (Plain with contrast)
  • Treatment:
    • Mirena (Levonorgestrel IUD) inserted
    • Tablet Megestrol 160 mg once daily (0-0-1)
  • Follow-up: Patient on medical management and regular follow-up
10 SUCCESS STORY 10
+
GANGLIONEUROMA – RARE CASE PRESENTATION
  • Patient: 12 years old child
  • Chief Complaints:
    • Lower abdominal pain – 2–3 months
    • Abdominal distension – 1 month
  • On Examination (P/A):
    • Abdomen distended
    • Tenderness present in right hypogastric region
    • Large mass occupying right hypogastric region
  • MRI Findings:
    • 9.1 x 7.2 x 8.2 cm well-lobulated cystic lesion in right adnexa
    • Right ovary not visualized separately
    • Likely benign complete right ovarian cystic lesion – ? Cystadenoma
  • Procedure: Diagnostic laparoscopy followed by laparotomy with right cystectomy
  • Intra-operative Findings:
    • Infantile uterus
    • Two cysts: 8x8 cm and 6x7 cm in retroperitoneum, adherent to each other
    • Right ureter lateralised
    • Cysts removed preserving the right ovary
  • Histopathology (HPE): Lesion revealed as Ganglioneuroma
  • Current Status: Patient on follow-up
11 CASE 11: ENDOMETRIAL STROMAL CELL CARCINOMA
+
ENDOMETRIAL STROMAL CELL CARCINOMA
Incidence:
Rare malignancy constituting 0.2% of uterine cancers
Annual incidence: 1–2 per million population
Clinical Presentation:
46-year-old nulligravida with:
  • Heavy menstrual bleeding for 5 months with passage of clots
  • Lower abdominal pain for 4 months
Per Vaginal Examination:
  • Mass felt: firm and globular
  • Cervix high up, uterus uniformly enlarged, immobile and nontender
  • No forniceal tenderness
Investigations:
  • Baseline investigations: Normal
  • Ultrasound:
    • Uterus with hypoechoic area suggestive of fibroid (6.5 × 6.2 cm, lateral wall)
    • Right ovary: 3.5 × 5.1 cm with 2 × 2 cm cyst
    • Left ovary: Multiloculated cyst measuring 5.2 × 5.1 cm
  • Pipelle biopsy: Endometrium in proliferative phase
Management:
  • Planned for Total Abdominal Hysterectomy with Bilateral Salpingo-Oophorectomy (TAH + BSO)
  • Post-operative HPE: Endometrial stromal cell carcinoma
Discussion:
Endometrial stromal sarcomas are rare malignant uterine tumors. Literature is limited to small series or case reports. Preoperative diagnosis is challenging, often discovered post-hysterectomy performed for presumed benign conditions like fibroids.
  • Imaging modalities (Ultrasound, MRI) and endometrial sampling can provide diagnostic clues
  • Total hysterectomy with bilateral salpingo-oophorectomy remains the cornerstone of treatment
  • Early detection offers potential for complete cure
Conclusion:
This case highlights an unexpected diagnosis of malignant uterine tumor mimicking leiomyoma clinically and radiologically. Histopathological examination remains the gold standard for diagnosing uterine sarcomas.

Central Laboratory

No Centarl Lab information available for this department.

Highlights

No Highlights information available for this department.

High Dependency Unit

No High Dependency Unit information available for this department.

Others

No Others information available for this department.

Scroll